Ozone exposure and systemic biomarkers: Evaluation of evidence for adverse cardiovascular health impacts

Critical Reviews in Toxicology

Volumn 45, Issue 5, 2015, Pages 412-452

  Goodman, Julie E ^a   Prueitt, Robyn L ^a   Sax, Sonja N ^a   Pizzurro, Daniella M ^a   Lynch, Heather N ^a   Zu, Ke ^a   Venditti, Ferdinand J ^b  

^a GRADIENT   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Air pollution; Biomarkers; Causal framework; Epidemiology; Inflammation; Mode of action; Ozone; Risk assessment; Weight of evidence

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; OZONE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; AIR POLLUTANT;

AIR QUALITY STANDARD; ANIMAL HOUSING; ANIMAL HUSBANDRY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLINDNESS; CARDIOVASCULAR DISEASE; CAUSAL ATTRIBUTION; CONFOUNDING VARIABLE; CORONARY ARTERY DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL PROTECTION; EXPERIMENTAL ANIMAL; HUMAN; INFLAMMATION; LAG TIME; LEUKOCYTE COUNT; LYMPHOCYTE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; POLLUTANT; QUALITY CONTROL; RANDOMIZATION; REPRODUCIBILITY; REVIEW; STATISTICAL ANALYSIS; STUDY DESIGN; ADVERSE EFFECTS; AIR POLLUTANT; ANIMAL; BLOOD; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; ENVIRONMENTAL MONITORING; EXPOSURE; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TOXICITY TESTING;

ANIMALIA;

AIR POLLUTANTS; ANIMALS; BIOMARKERS; CARDIOVASCULAR DISEASES; ENVIRONMENTAL MONITORING; HUMANS; INHALATION EXPOSURE; OZONE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TOXICITY TESTS;

EID: 84929172237     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2015.1031371     Document Type: Review

References (122)

1. Baccarelli A, Zanobetti A, Martinelli I, Grillo P, Hou L, Lanzani G, et al. (2007a). Air pollution, smoking, and plasma homocysteine. Environ Health Perspect, 115, 176-81.
2. Baccarelli A, Zanobetti A, Martinelli I, Grillo P, Hou L, Giacomini S, et al. (2007b). Eff ects of exposure to air pollution on blood coagulation. J Thromb Haemost, 5, 252-60.
3. Barath S, Langrish JP, Lundback M, Bosson JA, Goudie C, Newby DE, et al. (2013). Short-term exposure to ozone does not impair vascular function or aff ect heart rate variability in healthy young men. Toxicol Sci, 135, 292-9.
4. Bell ML, Dominici F, Samet JM. (2005). A meta-analysis of timeseries studies of ozone and mortality with comparison to the National Morbidity, Mortality, and Air Pollution Study. Epidemiology, 15, 436-45.
5. Bergamaschi E, De Palma G, Mozzoni P, Vanni S, Vettori MV, Broeckaert F, et al. (2001). Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute eff ects. Am J Respir Crit Care Med, 163, 1426-31.
6. Berrahmoune H, Lamont JV, Herbeth B, Fitzgerald PS, Visvikis-Siest S. (2006). Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: results from the STANISLAS cohort. Clin Chem, 52, 504-10.
7. Bhutia Y, Ghosh A, Sherpa ML, Pal R, Mohanta PK. (2011). Serum malondialdehyde level: surrogate stress marker in the Sikkimese diabetics. J Nat Sci Biol Med, 2, 107-12.
8. Bind MA, Baccarelli A, Zanobetti A, Tarantini L, Suh H, Vokonas P, Schwartz J. (2012). Air pollution and markers of coagulation, infl ammation, and endothelial function: associations and epigene-environment interactions in an elderly cohort. Epidemiology, 23, 332-40.
9. Bobb GA, Fairchild EJ. (1967). Neutrophil-to-lymphocyte ratio as indicator of ozone exposure. Toxicol Appl Pharmacol, 11, 558-64.
10. Bouthillier L, Vincent R, Goegan P, Adamson IY, Bjarnason S, Stewart M, et al. (1998). Acute eff ects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am J Pathol, 153, 1873-84.
11. Brook RD, Urch B, Dvonch JT, Bard RL, Speck M, Keeler G, et al. (2009). Insights into the mechanisms and mediators of the eff ects of air pollution exposure on blood pressure and vascular function in healthy humans. Hypertension, 54, 659-67.
12. Bruske I, Hampel R, Baumgartner Z, R kerl R, Greven S, Koenig W, et al. (2011). Ambient air pollution and lipoprotein-associated phospholipase A2 in survivors of myocardial infarction. Environ Health Perspect, 119, 921-6.
13. Buckley RD, Hackney JD, Clark K, Posin C. (1975). Ozone and human blood. Arch Environ Contam, 30, 40-3.
14. Chen C, Arjomandi M, Balmes J, Tager I, Holland N. (2007). Eff ects of chronic and acute ozone exposure on lipid peroxidation and antioxidant capacity in healthy young adults. Environ Health Perspect, 115, 1732-7.
15. Chhabra SK, Yasir A, Chaudhry K, Shah B. (2010). Eff ect of ozone on response to ovalbumin & its modulation by vitamins C & E in sensitized guinea pigs. Indian J Med Res, 132, 87-93.
16. Chuang GC, Yang Z, Westbrook DG, Pompilius M, Ballinger CA, White CR, et al. (2009). Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis. Am J Physiol Lung Cell Mol Physiol, 297, L209-16.
17. Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS. (2007). The eff ect of urban air pollution on infl ammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J Respir Crit Care Med, 176, 370-6.
18. Chuang KJ, Yan YH, Cheng TJ. (2010). Eff ect of air pollution on blood pressure, blood lipids, and blood sugar: a population-based approach. J Occup Environ Med, 52, 258-62.
19. Cigni A, Pileri PV, Faedda R, Gallo P, Sini A, Satta AE, et al. (2014). Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor a in active and quiescent systemic lupus erythematosus. J Invest Med, 62, 825-9. doi:10.231/JIM.0000000000000085.
20. Cole MP, Freeman BA. (2009). Promotion of cardiovascular disease by exposure to the air pollutant ozone. Am J Physiol Lung Cell Mol Physiol, 297, L205-8.
21. Cretu DI, Sovrea A, Ignat RM, Filip A, Bidian C, Cretu A. (2010). Morpho-pathological and physiological changes of the brain and liver after ozone exposure. Rom J Morphol Embryol, 51, 701-6.
22. Davidson MH, Corson MA, Alberts MJ, Anderson JL, Gorelick PB, Jones PH, et al. (2011). Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines. Am J Cardiol, ( 101 Suppl), 51F-7F. doi:10.1016/j.amjcard.2008.04.019
23. Delfi no RJ, Staimer N, Tjoa T, Arhami M, Polidori A, Gillen DL, et al. (2010). Associations of primary and secondary organic aerosols with airway and systemic infl ammation in an elderly panel cohort. Epidemiology, 21, 892-902.
24. Devlin RB, Duncan KE, Jardim M, Schmitt MT, Rappold AG, Diaz-Sanchez D. (2012). Controlled exposure of healthy young volunteers to ozone causes cardiovascular eff ects. Circulation, 126, 104-11.
25. Dittman WA, Majerus PW. (1990). Structure and function of thrombomodulin: a natural anticoagulant. Blood, 75, 329-36.
26. Donde A, Wong H, Frelinger J, Power K, Balmes JR, Arjomandi M. (2012). Eff ects of exercise on systemic infl ammatory, coagulatory, and cardiac autonomic parameters in an inhalational exposure study. J Occup Environ Med, 54, 466-70.
27. dos Santos Silva I. (1999). Cancer epidemiology: principles and methods. International Agency for Research on Cancer (IARC) (Lyon, France), 442 p.
28. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. (1991). Publication bias in clinical research. Lancet, 337, 867-72.
29. Feng R, He W, Ochi H. (2001). A new murine oxidative stress model associated with senescence. Mech Ageing Dev, 122, 547-59.
30. Folsom AR. (2013). Classical and novel biomarkers for cardiovascular risk prediction in the United States. J Epidemiol, 23, 158-62. doi:10.2188/jea.JE20120157
31. Franklin M, Schwartz J. (2008). The impact of secondary particles on the association between ambient ozone and mortality. Environ Health Perspect, 116, 453-8.
32. Fujimaki H, Shiraishi F, Ashikawa T, Murakami M. (1987). Changes in delayed hypersensitivity reaction in mice exposed to O 3. Environ Res, 43, 186-90.
33. Gilstrap LG, Wang TJ. (2012). Biomarkers and cardiovascular risk assessment for primary prevention: an update. Clin Chem, 58, 72-82.
34. Gong H, Wong R, Sarma RJ, Linn WS, Sullivan ED, Shamoo DA, et al. (1998). Cardiovascular eff ects of ozone exposure in human volunteers. Am J Respir Crit Care Med, 158, 538-46.
35. Goodman JE, Prueitt RL, Sax SN, Bailey LA, Rhomberg LR. (2013). Evaluation of the causal framework used for setting National Ambient Air Quality Standards. Crit Rev Toxicol, 43, 829-49. doi:10.3109/10 408444.2013.837864.
36. Goodman JE, Prueitt RL, Sax SN, Lynch HN, Zu K, Lemay JC, et al. (2014). Weight-of-evidence evaluation of short-term ozone exposure and cardiovascular eff ects. Crit Rev Toxicol 44 725-90. doi:10.3109/10408444.2014.937854.
37. Goodman JE, Sax SN, Lange S, Rhomberg LR. (2015). Are the elements of the proposed ozone National Ambient Air Quality Standards based on the best available science Reg Toxicol Pharmacol. In press.
38. Hatch GE, McKee J, Brown J, McDonnell W, Seal E, Soukup J, et al. (2013). Biomarkers of dose and eff ect of inhaled ozone in resting versus exercising human subjects: comparison with resting rats. Biomark Insights, 8, 53-67.
39. Hatch GE, Slade R, Harris LP, McDonnell WF, Devlin RB, Koren HS, et al. (1994). Ozone dose and eff ect in humans and rats. A comparison using oxygen,-18 labeling and bronchoalveolar lavage. Am J Respir Crit Care Med, 150, 676-83.
40. Helena Laboratories. (2012). Helena platelet aggregation reagents. Cat. No. 5366, 5367, 5368, 5369. Available at: http://www.helena.com/Procedures/Pro063Rev7.pdf. Accessed on 9 December 2014.
41. Hill AB. (1965). The environment and disease: association or causation Proc R Soc Med, 58, 295-300.
42. Institute of Medicine (IOM).(2008). Improving the Presumptive Disability Decision-Making Process for Veterans. Committee on Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Board on Military and Veterans Health. National Academies Press [Online]. 781p. Available at: http://books.nap.edu/openbook. phprecord-id-11908. Accessed on 9 October 2009.
43. Insull W. (2009). The pathology of atherosclerosis: Plaque development and plaque responses to medical treatment. Am J Med, 122(Suppl 1), S3-S14.
44. Jakubowski K, Jedlinska-Krakowska M, Siwicki AK. (2004). The level of some acute phase proteins, total protein, gamma-globulins and activity of lysozyme in blood plasma of rats supplemented with vitamin E and exposed to ozone. Pol J Vet Sci, 7, 283-7.
45. Jerrett M, Burnett RT, Pope CA, Ito K, Thurston G, Krewski D, et al. (2009). Long-term ozone exposure and mortality. N Engl J Med, 360, 1085-95.
46. Kadiiska MB, Basu S, Brot N, Cooper C, Saari Csallany A, Davies MJ, et al. (2013). Biomarkers of oxidative stress study V: ozone exposure of rats and its eff ect on lipids, proteins, and DNA in plasma and urine. Free Radic Biol Med, 61, 408-15. doi:10.1016/j. freeradbiomed.2013.04.023.
47. Kadiiska MB, Hatch GE, Nyska A, Jones DP, Hensley K, Stocker R, et al. (2011). Biomarkers of oxidative stress study IV: ozone exposure of rats and its eff ect on antioxidants in plasma and bronchoalveolar lavage fl uid. Free Radic Biol. Med, 51, 1636-42. doi:10.1016/j. freeradbiomed.2011.07.013.
48. Kamath S, Lip GYH. (2003). Fibrinogen: biochemistry, epidemiology and determinants. QJM, 96, 711-29.
49. Katsouyanni K, Samet JM, Anderson HR, Atkinson R, Le Tertre A, Medina S, et al. (2009). Air Pollution and Health: a European and North American Approach (APHENA). Res Rep Health Eff Inst, 142, 5-90.
50. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. (2010). Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol, 8, e1000412.
51. Kodavanti UP, Thomas R, Ledbetter AD, Schladweiler MC, Shannahan JH, Wallenborn JG, et al. (2011). Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles. Environ Health Perspect, 119, 312-18.
52. Lee PC, Talbott EO, Roberts JM, Catov JM, Sharma RK, Ritz B. (2011). Particulate air pollution exposure and C-reactive protein during early pregnancy. Epidemiology, 22, 524-31.
53. Leikin JB, Paloucek FP. (2008). Poisoning and Toxicology Handbook, 4th edition. New York, NY: Informa Healthcare USA, Inc.
54. Lewington S, Bragg F, Clarke R. (2012). A review on metaanalysis of biomarkers: promises and pitfalls. Clin Chem, 58, 1192-204.
55. Liao D, Heiss G, Chinchilli VM, Duan Y, Folsom AR, Lin HM, Salomaa V. (2005). Association of criteria pollutants with plasma hemostatic/infl ammatory markers: a population-based study. J Expo Anal Environ Epidemiol, 15, 319-28.
56. Libby P, Ridker PM, Hansson GK. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature, 473, 317-25.
57. Libby P. (2001). Prevention and treatment of atherosclerosis. In: Braunwald, E, Fauci, AS, Kasper, DL, Hauser, SL, Longo, DL, Jameson, JL, eds. Harrison ' ' s Principles of Internal Medicine, 15th edition. New York: McGraw-Hill, pp. 1382-6.
58. Lipsett MJ, Ostro BD, Reynolds P, Goldberg D, Hertz A, Jerrett M, et al. (2011). Long-term exposure to air pollution sand cardiorespiratory disease in the California teachers study cohort. Am J Respir Crit Care Med, 184, 828-35.
59. Liu L, Kumarathasan P, Guenette J, Vincent R. (1996). Hydroxylation of salicylate in lungs of Fischer 344 rats: eff ects of aging and ozone exposure. Am J Physiol, 271(6 pt. 1), L995-1003.
60. Liu L, Leech JA, Urch RB, Poon R, Zimmerman B, Kubay JM, Silverman FS. (1999). A comparison of biomarkers of ozone exposure in human plasma, nasal lavage, and sputum. Inhal Toxicol, 11, 657-74.
61. Liu L, Leech JA, Urch RB, Silverman FS. (1997). In vivo salicylate hydroxylation: a potential biomarker for assessing acute ozone exposure and eff ects in humans. Am J Respir Crit Care Med, 156, 1405-12.
62. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaff arian D, Appel LJ, Van Horn L, et al. (2010). Defi ning and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association ' ' s strategic impact goal through 2020 and beyond. Circulation, 121, 586-613.
63. Lorente L, Martin MM, Abreu-Gonzalez P, Dominguez-Rodriguez A, Labarta L, Diaz C, et al. (2013). Prognostic value of malondialdehyde serum levels in severe sepsis: a multicenter study. PLoS ONE, 8, e53741.
64. Martinez-Campos C, Lara-Padilla E, Bobadilla-Lugo RA, Kross RD, Villanueva C. (2012). Eff ects of exercise on oxidative stress in rats induced by ozone. Scientifi cWorldJournal, 2012, 135921.
65. Medinsky MA. (1996). Determinants of gas and vapor uptake in the respiratory tract. CIIT Activities, 16, 1-6.
66. Miller FJ. (1995). Uptake and fate of ozone in the respiratory tract. Toxicol Lett, 82-83, 277-85.
67. Mole ML Jr, Stead AG, Gardner DE, Miller FJ, Graham JA. (1985). Eff ect of ozone on serum lipids and lipoproteins in the rat. Toxicol Appl Pharmacol, 80, 367-76.
68. Montgomery JE, Brown JR. (2013). Metabolic biomarkers for predicting cardiovascular disease. Vasc Health Risk Manag, 9, 37-45.
69. Mooij CF, Kroese JM, Sweep FC, Hermus AR, Tack CJ. (2011). Adult patients with congenital adrenal hyperplasia have elevated blood pressure but otherwise a normal cardiovascular risk profi le. PLoS ONE, 6, e24204. doi:10.1371/journal.pone.0024204.
70. Moore KJ, Sheedy FJ, Fisher EA. (2013). Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol, 13, 709-21. doi:10.1038/nri3520.
71. Nachtman JP, Moon HL, Miles RC. (1988). Ozone inhalation in rats: eff ects on alkaline phosphatase and lactic dehydrogenase isoenzymes in lavage and plasma. Bull Environ Contam Toxicol, 41, 502-7
72. National Library of Medicine (NLM). (2014). HazMap for ozone (CAS No. 10028-15-6). Available at: http://hazmap.nlm.nih.gov/categorydetails id-68 & table-copytblagents. Accessed on 12 May 2014.
73. National Research Council (NRC). Committee on Tropospheric Ozone Formation and Measurement. (1991). Rethinking the ozone problem in urban and regional air pollution. Washington, DC: National Academy Press, 523 p.
74. Navarro SL, Brasky TM, Schwarz Y, Song X, Wang CY, Kristal AR, et al. (2012). Reliability of serum biomarkers of infl ammation from repeated measures in healthy individuals. Cancer Epidemiol Biomarkers Prev, 21, 1167-770. doi:10.1158/1055-9965.EPI-12-0110.
75. Organisation for Economic Co-operation and Development (OECD).(1998). OECD Principles on Good Laboratory Practice (Revised). Environment Directorate, Chemicals Group and Management Committee. EN, V/MC/CHEM(98), 17. OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring 1. 41p. January 21.
76. Organisation for Economic Co-operation and Development (OECD). (2009). OECD Guideline for the Testing of Chemicals: subchronic Inhalation Toxicity: 28-Day Study. OECD, 412. 14p. September 7.
77. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. (2003). Markers of infl ammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499-511. doi:10.1161/01.CIR.0000052939.59093.45.
78. Pekkanen J, Brunner EJ, Anderson HR, Tiittanen P, Atkinson RW. (2000). Daily concentrations of air pollution and plasma fi brinogen in London. Occup Environ Med, 57, 818-22.
79. Perepu RS, Dostal DE, Garcia C, Kennedy RH, Sethi R. (2012). Cardiac dysfunction subsequent to chronic ozone exposure in rats. Mol Cell Biochem, 360, 339-45.
80. Perepu RS, Garcia C, Dostal D, Sethi R. (2010). Enhanced death signaling in ozone-exposed ischemic-reperfused hearts. Mol Cell Biochem, 336, 55-64.
81. Petito Boyce C, Goodman JE, Sax SN, Loftus CT. (2015). Providing perspective for interpreting cardiovascular mortality risks associated with ozone exposures. Reg Tox Pharmacol, doi: 10.1016/j.yrtph.2015.03.009
82. Poursafa P, Kelishadi R, Lahijanzadeh A, Modaresi M, Javanmard SH, et al. (2011). The relationship of air pollution and surrogate markers of endothelial dysfunction in a population-based sample of children. BMC Public Health, 11, 115.
83. Prueitt RL, Lynch HN, Zu K, Sax SN, Venditti FJ, Goodman JE. (2014). Weight-of-evidence evaluation of long-term ozone exposure and cardiovascular eff ects. Crit Rev Toxicol, 44, 791-822. doi:10.3109/10408444.2014.937855.
84. Ren C, Fang S, Wright RO, Suh H, Schwartz J. (2011). Urinary 8-hydroxy-2 '-deoxyguanosine as a biomarker of oxidative DNA damage induced by ambient pollution in the Normative Aging Study. Occup Environ Med, 68, 562-9.
85. Rhomberg LR, Bailey LA, Goodman JE. (2010). Hypothesis-based weight of evidence: a tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action-Naphthalene as an example. Crit Rev Toxicol, 40, 671-96.
86. Rhomberg LR, Goodman JE, Bailey LA, Prueitt RL, Beck NB, Bevan C, et al. (2013). A survey of frameworks for best practices in weight-ofevidence analyses. Crit Rev Toxicol, 43, 753-84. doi:10.3109/10408 444.2013.832727.
87. Rich DQ, Kipen HM, Huang W, Wang G, Wang Y, Zhu P, et al. (2012). Association between changes in air pollution levels during the Beijing Olympics and biomarkers of infl ammation and thrombosis in healthy young adults. JAMA, 307, 2068-78.
88. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of fi rst cardiovascular events. N Engl J Med, 347, 1557-65.
89. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. (2000). Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 101, 1767-72. doi: 10.1161/01.CIR.101.15.1767.
90. Rudez G, Janssen NA, Kilinc E, Leebeek FW, Gerlofs-Nijland ME, Spronk HM, et al. (2009). Eff ects of ambient air pollution on hemostasis and infl ammation. Environ Health Perspect, 117, 995-1001.
91. Sadler JE. (2003). Von Willebrand disease type 1: a diagnosis in search of a disease. Blood, 101, 2089-93.
92. Sanchez-Gonzalez DJ, Moro MA, Castillo-Henkel C, Herrera-Gonzalez N, Hernandez-Pando R, LariosMedina FJ, et al. (2004). Ozone exposure induces iNOS expression and tyrosine nitration in rat aorta. Environ Toxicol Pharmacol, 17, 1-7.
93. Sarwar N, Thompson AJ, Di Angelantonio E. (2009). Markers of infl ammation and risk of coronary heart disease. Dis Markers, 26, 217-25.
94. Schwartz J. (2001). Air pollution and blood markers of cardiovascular risk. Environ Health Perspect, ( 109 Suppl 3), 405-9.
95. Sethi R, Manchanda S, Perepu RS, Kumar A, Garcia C, Kennedy RH, et al. (2012). Diff erential expression of caveolin-1 and caveolin-3: potential marker for cardiac toxicity subsequent to chronic ozone inhalation. Mol Cell Biochem, 369, 9-15.
96. Siddiqi N. (2011). Publication bias in epidemiological studies. Cent Eur J Public Health, 19, 118-20.
97. Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CGM. (1994). Levels of soluble VCAM1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE), a long term prospective study. Clin Exp Immunol, 97, 439-44.
98. Steinvil A, Kordova-Biezuner L, Shapira I, Berliner S, Rogowski O. (2008). Short-term exposure to air pollution and infl ammation-sensitive biomarkers. Environ Res, 106, 51-61.
99. Stoner L, Lucero AA, Palmer BR, Jones LM, Young JM, Faulkner J. (2013). Infl ammatory biomarkers for predicting cardiovascular disease. Clin Biochem, 46, 1353-71. doi:10.1016/j.clinbiochem.2013.05.070.
100. Strak M, Hoek G, Steenhof M, Kilinc E, Godri KJ, Gosens I, et al. (2013). Components of ambient air pollution aff ect thrombin generation in healthy humans: the RAPTES project. Occup Environ Med, 70, 332-40.
101. Sun L, Liu C, Xu X, Ying Z, Maiseyeu A, Wang A, et al. (2013). Ambient fi ne particulate matter and ozone exposures induce infl ammation in epicardial and perirenal adipose tissues in rats fed a high fructose diet. Part Fibre Toxicol, 10, 43.
102. Takatori T. (1975). Eff ect of ozone exposure on lecithin: cholesterol acyltransferase activity in rat serum. Hokkaido Igaku Zasshi, 50, 567-70.
103. Taubes G. (1995). Epidemiology faces its limits. Science, 269, 164-9.
104. Thompson AM, Zanobetti A, Silverman F, Schwartz J, Coull B, Urch B, et al. (2010). Baseline repeated measures from controlled human exposure studies: associations between ambient air pollution exposure and the systemic infl ammatory biomarkers IL-6 and fi brinogen. Environ Health Perspect, 118, 120-4.
105. Thomson E, Kumarathasan P, Vincent R. (2006). Pulmonary expression of preproET-1 and preproET-3 mRNAs is altered reciprocally in rats after inhalation of air pollutants. Exp Biol Med, 231, 979-84.
106. Urch B, Speck M, Corey P, Wasserstein D, Manno M, Lukic KZ, et al. (2010). Concentrated ambient fi ne particles and not ozone induce a systemic interleukin-6 response in humans. Inhal Toxicol, 22, 210-18
107. USEPA. (1998). Health Eff ects Test Guidelines: OPPTS 870.1000-acute Inhalation Toxicity. Offi ce of Prevention, Pesticides and Toxic Substances. EPA, 712-C-98193. 11p. August.
108. USEPA. (2009). Integrated Science Assessment for Particulate Matter (Final). Offi ce of Research and Development, National Center for Environmental Assessment (NCEA)-RTP Division. EPA/600/R-08/139F. 2228p. December. Available at: http://www.epa.gov/ncea/pdfs/partmatt/Dec2009/PM-ISA-full.pdf. Accessed on 3 February 2010
109. USEPA. (2013). Integrated Science Assessment for Ozone and Related Photochemical Oxidants (Final). National Center for Environmental Assessment (NCEA). EP, A/600/R-10/076F. 1251p. February.
110. Vaughan WJ, Adamson GL, Lindgren FT, Schooley JC. (1984). Serum lipid and lipoprotein concentrations following exposure to ozone. J Environ Pathol Toxicol Oncol, 5, 165-73.
111. Vesely DL, Giordano AT, Raska-Emery P, Montgomery MR. (1994a). Ozone increases atrial natriuretic peptides in heart, lung and circulation of aged vs. adult animals. Gerontology, 40, 227-36.
112. Vesely DL, Giordano AT, Raska-Emery P, Montgomery MR. (1994b). Ozone increases amino-and carboxy-terminal atrial natriuretic factor prohormone peptides in lung, heart, and circulation. J Biochem Toxicol, 9, 107-12.
113. Vesely DL, Giordano AT, Raska-Emery P, Montgomery MR. (1994c). Increase in atrial natriuretic factor in the lungs, heart, and circulatory system owing to ozone. Chest, 105, 1551-4.
114. Vingarzan R. (2004). A review of surface ozone background levels and trends. Atmos Environ, 38, 3431-42.
115. Walldius G, Jungner I. (2005). Rationale for using apolipoprotein B and apolipoprotein A-Ias indicators of cardiac risk and as targets for lipid-lowering therapy (Letter). Eur Heart J, 26, 210-12. doi:10.1093/eurheartj/ehi077.
116. Wang G, Jiang R, Zhao Z, Song W. (2013). Eff ects of ozone and fi ne particulate matter (PM(2.5)) on rat system infl ammation and cardiac function. Toxicol Lett, 217, 23-33.
117. World Health Organization (WHO). (2009). Handbook: good Laboratory Practice (GLP): quality Practices for Regulated Non-Clinical Research and Development (Second Edition). Special Programme for Research and Training in Tropical Diseases (TDR). Report to United Nations Children ' s Fund (UNICEF, ); United Nations Development Programme (UNDP); World Bank. 328p.
118. Zakynthinos E, Pappa N. (2009). Infl ammatory biomarkers in coronary artery disease. J Cardiology, 53, 317-33. doi:10.1016/j. jjcc.2008.12.007.
119. Zhang J, Zhu T, Kipen H, Wang G, Huang W, Rich D, et al. (2013). Cardiorespiratory Biomarker Responses in Healthy Young Adults to Drastic Air Quality Changes Surrounding the 2008 Beijing Olympics. HEI Research Report 174. Health Eff ects Institute, Boston, MA. 200p. February. Available at: http://pubs.healtheff ects.org/getfi le. phpu-912. Accessed on 8 November 2013.
120. Zhang L, Jacob DJ, Downey NV, Wood DA, Blewitt D, Carouge CC, et al. (2011). Improved estimate of the policy-relevant background ozone in the United States using the GEOS-Chem global model with 2/3 horizontal resolution over North America. Atmos Environ, 45, 6769-76.
121. Zhang S, Bai YY, Luo LM, Xiao WK, Wu HM, Ye P. (2014). Association between serum homocysteine and arterial stiffness in elderly: a community-based study. J Geriatr Cardiol, 11, 32-8. doi:10.3969/j. issn.1671-5411.2014.01.007.
122. Zhou X, Fragala MS, McElhaney JE, Kuchel GA. (2010). Conceptual and methodological issues relevant to cytokine and infl ammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care, 13, 541-7.